All Stories

  1. Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data

    Article • Journal of Alzheimer s Disease, December 2021, IOS Press

    Poul Høilund-Carlsen

  2. Does therapy of the primary tumor matter in oligometastatic prostate cancer? A prospective 10-year follow-up study

    Article • Research and Reports in Urology, July 2019, Dove Medical Press

    Lars Lund, Poul Høilund-Carlsen

  3. PET imaging in Alzheimer's disease

    Article • Journal of Alzheimer s Disease, April 2018, IOS Press

    Poul Høilund-Carlsen